Empty Capsules Market (By Type: Gelatin Capsules, Non-gelatin Capsules; By Functionality: Immediate-released, Sustained-released, Delayed-released, By Application: Antibiotics, Antacids, Anti-inflammatory, Cough; By End user: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceuticals Companies, Research Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global empty capsules market size was valued at USD 3.14 billion in 2023 and is anticipated to reach around USD 6.01 billion by 2033, growing at a CAGR of 6.70% from 2024 to 2033. The rising demand for dietary supplements and the adoption of capsule-based drugs are driving the growth of the market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. empty capsules market size was estimated at USD 770 million in 2023 and is projected to surpass around USD 1,470 million by 2033 at a CAGR of 6.76% from 2024 to 2033.
North America led the empty capsules market with the largest market size in 2023. The growth of the market in the region is attributed to the well-developed healthcare infrastructure and the rising number of pharmaceutical industries that led to the higher demand for empty capsules for drug packaging.
The increasing investments in research and development activities in the development of the pharmaceutical industry and for the latest drug launch drive the expansion of the pharmaceutical industry. The rising prevalence of chronic diseases in the population due to unhealthy lifestyles and the environment also contributes to the expansion of diseases and the demand for effective medicinal treatment. Thus, all these factors collectively contribute to the growth of the region's market.
Asia Pacific is expected to witness the fastest growth in the empty capsules market during the forecast period. The growth of the market in the region is expected to increase due to the rising investments in healthcare infrastructural development by the regional governments. The rising population around the region is one of the major reasons for the expanding healthcare and pharmaceutical industry and the rising geriatric population that is more likely to get the illnesses and diseases that drive the demand for long-term, medicinal treatment, which is further propelling the demand for the empty capsules market in the region.
Capsules are one of the types of medicines made from gelatin, cellulose, and polysaccharides. The capsule contains various types of drug formations, such as solid, liquid, and powder forms, that are made for swallowing. The drugs that are packed in the capsule may irritate the gastric mucosa and esophagus, volatilize easily, taste bad, decompose in saliva, or should be inhaled into the trachea. The packing of the active ingredient into the capsule prevents all these irritations and protects it from degradation and damaging organs and the respiratory tract. Based on consumer preference trends and clinical requirements, these capsules can be made soft and hard using a variety of materials.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 6.70% |
Global Market Size in 2023 | USD 3.14 Billion |
Global Market Size by 2033 | USD 6.01 Billion |
U.S. Market Size in 2023 | USD 770 Million |
U.S. Market Size by 2033 | USD 1,470 Million |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Type, By Functionality, By Application, and By End-user |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Increasing adoption of capsule drug formation for disease as well as health supplements market
The increasing prevalence of chronic diseases such as cancer, cardiovascular disease, gastrointestinal diseases, diabetes, etc., is driving the expansion of the drug market. The increasing adoption of the drug in capsule formation due to its better effects and easy intake drives the growth of the empty capsules market.
Along with therapeutic applications, the rising consumption of dietary supplements by people who come in capsule drug form leads to the increased demand for empty capsules in the market. The rising awareness about healthy lifestyles and dietary supplements for healthy gut health and the removal of skin issues contribute to the growth of the empty capsules market.
Restraint: Shortage of raw materials and cost-related constraints
The shortage of raw materials, such as gelatin, and the fluctuating prices of the raw materials are restraining the growth of the empty capsules market. In adverse conditions like economic crises, deteriorating trade relationships, or global healthcare situations as faced during the COVID pandemic, there is an acute shortage of raw materials along with limited funds. As the capsule has little to no effect on the mechanism of the active ingredient, pharmaceuticals tend to sway away from capsule-based delivery. Moreover, a sudden surge in prices of raw materials in response to growing demand and a broken supply chain further hinders market growth.
Opportunity: The rising potential of the pharmaceutical sector
The rising investment by the major private and government institutions in the development of the pharmaceutical sector is contributing to the growth of the market. The increasing research and development activities in the expansion of the market, product launches, and the latest drug development enhance the demand for empty capsules for the storage of drugs inside it for better consumption by the consumers. Additionally, the integration of technologies in the pharmaceutical manufacturing units for the improvement in quality and production drives the growth opportunities for the empty capsules market.
The gelatin segment dominated the empty capsules market in 2023. The growth of the segment is attributed to the rising use of the gelatine substance for capsule making due to its properties that drive demand for the segment. Water and gelatin are the two primary constituents of gelatin capsules. They are made from animal collagen, which is entirely different from those derived from plants.
Some types of gelatine capsules used in medicinal use are clear gelatin capsules, flavored gelatin capsules, and enteric-coated gelatin capsules. The gelatin capsules come in sizes of 5 to 000. Size 5 is the smallest size of the gelatin capsules, and size 000 is the biggest size of gelatin capsules. Each of them is used depending on the diameter of the capsules.
The immediate release segment is projected to witness the fastest growth in the empty capsules market during the forecast period. The system of oral medication delivery comprises solid dose forms, including immediate release and traditional forms. For the past few decades, a variety of acute and chronic disease therapies have been used in traditional dosage forms, such as capsules, solids, pills, powder, solutions, emulsions, and aerosols.
Using super disintegrants such as sodium starch glycolate (Primogel, Explotab), polyvinylpyrrolidone (PVP), etc., that enable rapid tablet disintegration after administration is the fundamental method employed in the development of immediate-release solid dosage forms. A variety of methods, such as direct compression and wet granulation, can be used to formulate it.
The antibiotics & antibacterial segment dominated the empty capsules market. The growth of the segment is attributed to the rising prevalence of chronic diseases and infectious diseases caused by bacteria. Antibiotics are a class of medications that are crucial for treating bacterial infections.
Medical practitioners utilize them to treat a variety of illnesses, including skin infections, urinary tract infections, meningitis, pneumonia, and strep throat. Some types of antibiotics used in the various symptoms of infections are Beta-lactam Antibiotics, Aminoglycosides, Sulfonamides, Quinolones, Macrolides, Nitroimidazole antibiotics, Tetracyclines, Lincosamides, Oxazolidinones and Lipoglycopeptides, and Glycopeptides.
The pharmaceutical companies segment held the largest share in the empty capsules market. The growth of the segment is attributed to the increasing expenditure and investments in the healthcare and pharmaceutical industry, which are driving the demand for the market the rising prevalence of chronic diseases that drives the demand for effective treatment and medication that drives the demand for empty capsules for the packing the drug which is on the form of power of liquid that contributed in the expansion of the empty capsules market. The increasing investments in the pharmaceutical industry by the public and private sectors are driving the expansion of the pharmaceutical industry.
Segments Covered in the Report
By Type
By Functionality
By Application
By End-user
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Empty Capsules Market
5.1. COVID-19 Landscape: Empty Capsules Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Empty Capsules Market, By Type
8.1. Empty Capsules Market Revenue and Volume Forecast, by Type, 2024-2033
8.1.1. Gelatin Capsules
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Non-gelatin Capsules
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Empty Capsules Market, By Functionality
9.1. Empty Capsules Market Revenue and Volume Forecast, by Functionality, 2024-2033
9.1.1. Immediate-released
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Sustained-released
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Delayed-released
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Empty Capsules Market, By Application
10.1. Empty Capsules Market Revenue and Volume Forecast, by Application, 2024-2033
10.1.1. Antibiotics
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Antacids
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Anti-inflammatory
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Cough
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Empty Capsules Market, By End-user
11.1. Empty Capsules Market Revenue and Volume Forecast, by End-user, 2024-2033
11.1.1. Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Nutraceutical Companies
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Cosmeceuticals Companies
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Research Laboratories
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Empty Capsules Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Functionality (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by End-user (2021-2033)
Chapter 13. Company Profiles
13.1. ACG Worldwide
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bright Pharma Caps Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. CapsCanada Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Lonza Group Ltd. (Capsugel)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Medi-Caps Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Roxlor LLC
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Snail Pharma Industry Co. Ltd
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Suheung Co., Ltd
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Sunil Healthcare Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client